1. Home
  2. Companies
  3. 1AD
  4. Announcements

AdAlta (ASX:1AD)

ASX announcement history & article coverage

26
Total announcements
(in last 3 months)
6
With article
20
No article
Article coverage
23%
Transparent by design. Announcments by AdAlta (ASX:1AD) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

2 July 2026 · 09:16 am AEST ASX Filing
Cleansing Notice
Cleansing Notice
2 July 2026 · 09:14 am AEST ASX Filing
Application for quotation of securities - 1AD
Appendix 2A
2 July 2026 · 09:13 am AEST ASX Filing
Application for quotation of securities - 1AD
Appendix 2A
2 July 2026 · 08:23 am AEST ⚡ Price SensitiveMaterial ASX Filing
Oktopi AI collaboration for research efficiency
AdAlta partners with Oktopi to boost AI-driven medicine development and strategic growth
Progress Report
70
1 July 2026 · 09:03 am AEST ⚡ Price SensitiveMaterial ASX Filing
Second BZDS1901 milestone paid
AdAlta completes milestone payment for BZDS1901 CAR-T, advancing manufacturing and FDA engagement
Progress Report
85
AdAlta Clears US$1M Milestone to Unlock BZDS1901 Data and Australian Manufacturing Healthcare Wrap - Week 27 (29 June -> 3 July) 2026 Wrap

25 June 2026 · 03:52 pm AEST ASX Filing
Cleansing Notice
Cleansing Notice
25 June 2026 · 03:50 pm AEST ASX Filing
Application for quotation of securities - 1AD
Appendix 2A
15 June 2026 · 05:56 pm AEST ASX Filing
Results of Meeting
Results of Meeting
9 June 2026 · 08:32 am AEST ASX Filing
Confirmation of results of Prospectus Offer
Issued Capital - OtherNotice of Meeting - Other

25 May 2026 · 08:53 am AEST ASX Filing
Proposed issue of securities - 1AD
Appendix 3B (Proposed issue of securities)
25 May 2026 · 08:51 am AEST ASX Filing
Target Market Determination
Other
25 May 2026 · 08:44 am AEST ⚡ Price SensitiveMaterial ASX Filing
Prospectus
AdAlta launches option offer to fund CAR-T therapy development following $2.5M placement
PlacementDisclosure Document
75
25 May 2026 · 08:17 am AEST ⚡ Price SensitiveMaterial ASX Filing
Regulatory advisors appointed for BZDS1901
AdAlta engages FDA advisors to advance CAR-T therapy BZDS1901 for mesothelioma
Progress Report
75
AdAlta Taps FDA Expertise to Fast-Track CAR-T Therapy for Mesothelioma Healthcare Wrap - Week 22 (25 May -> 29 May) 2026 Wrap
18 May 2026 · 09:38 am AEST ASX Filing
Cleansing Notice
Cleansing Notice
18 May 2026 · 08:55 am AEST ASX Filing
Application for quotation of securities - 1AD
Appendix 2A
15 May 2026 · 09:41 am AEST ASX Filing
Notice of EGM & Proxy Form
Notice of Extraordinary General MeetingProxy Form
11 May 2026 · 12:12 pm AEST ASX Filing
Webinar presentation - new hope for mesothelioma patients
Company Presentation
7 May 2026 · 08:25 am AEST ASX Filing
Investor webinar - new hope for mesothelioma patients
Web Cast
4 May 2026 · 01:57 pm AEST ASX Filing
Proposed issue of securities - 1AD
Appendix 3B (Proposed issue of securities)
4 May 2026 · 09:48 am AEST ASX Filing
Proposed issue of securities - 1AD
Appendix 3B (Proposed issue of securities)
4 May 2026 · 09:47 am AEST ⚡ Price SensitiveMaterial ASX Filing
$2.5m placement
AdAlta raises A$2.5M to advance CAR-T therapy BZDS1901 with FDA and manufacturing milestones
PlacementTrading Halt Lifted
85
AdAlta Raises A$2.5M to Advance CAR-T Therapy BZDS1901 with FDA and Manufacturing Milestones Market Wrap - Week 19 (4 May -> 8 May) 2026 Wrap Healthcare Wrap - Week 19 (4 May -> 8 May) 2026 Wrap

30 Apr 2026 · 08:49 am AEST ⚡ Price Sensitive ASX Filing
Trading Halt
Trading Halt
30 Apr 2026 · 08:31 am AEST ⚡ Price SensitiveMaterial ASX Filing
Quarterly Appendix 4C and Activities Report
AdAlta launches East-to-West CAR-T strategy with promising mesothelioma therapy and Australian manufacturing transfer
Commitments Test Entity - Third Quarter Activity ReportCommitments Test Entity - Third Quarter Cashflow Report
85
AdAlta Advances CAR-T Therapy with East-to-West Strategy and Australian Manufacturing Transfer
29 Apr 2026 · 08:23 am AEST ⚡ Price SensitiveMaterial ASX Filing
BZDS1901 manufacturing agreement
AdAlta initiates Australian manufacturing of promising CAR-T therapy BZDS1901 for advanced mesothelioma
Progress Report
85
AdAlta Moves Manufacturing of CAR-T Therapy to Australia After Rare Tumour Clearance Market Wrap - Week 18 (27 Apr -> 1 May) 2026 Wrap Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026 Wrap
21 Apr 2026 · 09:17 am AEST ⚡ Price SensitiveMaterial ASX Filing
Automated cell therapy manufacturing MoU
AdAlta, Oribiotech, and Cell Therapies partner to deploy automated cell therapy manufacturing platform in Asia Pacific
Progress Report
85
AdAlta and Partners Target Cell Therapy Scale-Up with Automated IRO Platform Healthcare Wrap - Week 17 (20 Apr -> 24 Apr) 2026 Wrap
17 Apr 2026 · 09:40 am AEST ASX Filing
Board Change and Appendix 3Z
Final Director's Interest NoticeDirector Appointment/Resignation